GC analysis of imidazopyrazole in plasma using nitrogen-specific detection

Area of Science:

• Analytical Chemistry
• Pharmacokinetics
• Clinical Chemistry

Background:

• Imidazopyrazole requires precise quantification in biological matrices for pharmacokinetic analysis.
• Existing analytical methods may lack the sensitivity or specificity needed for low-dose studies.

Purpose of the Study:

• To develop and validate a sensitive and specific gas chromatography (GC) assay for quantifying imidazopyrazole in human plasma.
• To establish a reliable method for supporting pharmacokinetic and clinical studies of imidazopyrazole.

Main Methods:

• Plasma samples were extracted using methylene chloride with 7-bromo-imidazopyrazole as an internal standard.
• The extract was derivatized with pentaflourobenzoyl chloride.
• Analysis was performed using gas chromatography with nitrogen-specific detection on an OV-17 column.

Main Results:

• The assay demonstrated linearity over a concentration range of 0.045-40 µg/ml.
• The practical limit of sensitivity was 50 ng/ml.
• Between-run variability showed a coefficient of variation of 5.1%.

Conclusions:

• A sensitive, specific, and reproducible GC assay for imidazopyrazole in plasma was successfully developed.
• The validated method is suitable for pharmacokinetic investigations and clinical trials, including pediatric studies.